Frederick D. Sancilio Ms.PhD

Dr. Sancilio is a serial entrepreneur in the healthcare field and is currently a principle of Clearway Global, Inc., a pharmaceutical development advisory service. He has served as an executive and director of both private and public companies, including Applied Analytical Industries Inc., aaiPharma, Inc., Endeavor Pharmaceutical Company, Aesgen, Inc., Sancilio & Company, Alpha Cognition, Inc., TrippBio, Inc., Omega Blu, LLC, and Nation’s Bank of North Carolina. Dr. Sancilio has participated in the development of more than 40 drug product patents that have been granted by the United States Patent and Trademark Office. He was appointed as a Research Professor at Florida Atlantic University and was an adjunct professor of chemistry at the University of North Carolina. Dr. Sancilio received his Master of Science and Doctorate degrees from Rutgers, The State University of New Jersey.